Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis

BACKGROUND: Resistance to apoptosis is a major problem in ovarian cancer (OC) and correlates with poor prognosis. Osteoprotegerin (OPG) is a soluble secreted factor that acts as a decoy receptor for receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-related apoptosis-inducing ligan...

Descripción completa

Detalles Bibliográficos
Autores principales: Lane, Denis, Matte, Isabelle, Laplante, Claude, Garde-Granger, Perrine, Rancourt, Claudine, Piché, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874685/
https://www.ncbi.nlm.nih.gov/pubmed/24267510
http://dx.doi.org/10.1186/1757-2215-6-82

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874685/
https://www.ncbi.nlm.nih.gov/pubmed/24267510
http://dx.doi.org/10.1186/1757-2215-6-82

Ejemplares similares